View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
TREAS/IRS | RIN: 1545-BJ39 | Publication ID: Spring 2014 |
Title: Branded Prescription Drug Fee | |
Abstract: Implementation of section 9008 applies to imposition of annual fee on branded prescription pharmaceutical manufacturers and importers, of the Patient Protection and Affordable Care Act of 2010, Public Law 111-148. | |
Agency: Department of the Treasury(TREAS) | Priority: Substantive, Nonsignificant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Final Rule Stage |
Major: No | Unfunded Mandates: No |
CFR Citation: 26 CFR 51 | |
Legal Authority: 26 USC 7805 PL 111-148, sec 9008 26 USC 6302 |
Legal Deadline:
None |
||||||||||||
Timetable:
|
Additional Information: REG-112805-10 Drafting attorney: Celia Gabrysh (202) 317-6855 Reviewing attorney: Frank K. Boland (202) 317-6855 Treasury attorney: Christopher Kelley (202) 622-1357 CC:PSI | |
Regulatory Flexibility Analysis Required: No | Government Levels Affected: None |
Federalism: No | |
Included in the Regulatory Plan: No | |
RIN Data Printed in the FR: No | |
Related RINs: Related to 1545-BK34 | |
Agency Contact: Celia Gabrysh Attorney-Advisor (Tax) Department of the Treasury Internal Revenue Service 1111 Constitution Avenue NW., Room 5309, Washington, DC 20224 Phone:202 317-6855 Fax:202 317-6733 Email: celia.gabrysh@irscounsel.treas.gov |